142 related articles for article (PubMed ID: 7988251)
1. A phase 3 randomized trial of immediate combination chemotherapy vs delayed combination chemotherapy in patients with completely resected stage II and III non-small cell carcinoma of the lung.
Figlin RA; Piantodosi S
Chest; 1994 Dec; 106(6 Suppl):310S-312S. PubMed ID: 7988251
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small cell lung cancer. An LCSG Trial.
Feld R; Rubinstein L; Thomas PA
Chest; 1994 Dec; 106(6 Suppl):307S-309S. PubMed ID: 7988250
[TBL] [Abstract][Full Text] [Related]
3. Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large cell undifferentiated carcinoma.
Holmes EC
Chest; 1994 Dec; 106(6 Suppl):293S-296S. PubMed ID: 7988247
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. The Lung Cancer Study Group.
Feld R; Rubinstein L; Thomas PA
J Natl Cancer Inst; 1993 Feb; 85(4):299-306. PubMed ID: 8381187
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer. Results of a randomized prospective study. The Japan Clinical Oncology Group.
Ohta M; Tsuchiya R; Shimoyama M; Sawamura K; Mori T; Miyazawa N; Suemasu K; Watanabe Y; Tomita M; Terashima M
J Thorac Cardiovasc Surg; 1993 Oct; 106(4):703-8. PubMed ID: 8412266
[TBL] [Abstract][Full Text] [Related]
6. The comparison of CAP chemotherapy and radiotherapy to radiotherapy alone for resected lung cancer with positive margin or involved highest sampled paratracheal node (stage IIIA). LCSG 791.
Lad T
Chest; 1994 Dec; 106(6 Suppl):302S-306S. PubMed ID: 7988249
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.
Keller SM; Adak S; Wagner H; Herskovic A; Komaki R; Brooks BJ; Perry MC; Livingston RB; Johnson DH
N Engl J Med; 2000 Oct; 343(17):1217-22. PubMed ID: 11071672
[TBL] [Abstract][Full Text] [Related]
8. Postoperative adjuvant chemotherapy in non-small cell lung cancer: prognostic value of DNA ploidy and post-recurrent survival.
Ichinose Y; Hara N; Ohta M; Motohiro A; Kuda T; Aso H
J Surg Oncol; 1991 Jan; 46(1):15-20. PubMed ID: 1702493
[TBL] [Abstract][Full Text] [Related]
9. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
Imaizumi M;
Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
[TBL] [Abstract][Full Text] [Related]
10. Postoperative chemotherapy for non-small-cell lung cancer.
Holmes EC
Chest; 1993 Jan; 103(1 Suppl):30S-34S. PubMed ID: 8380131
[TBL] [Abstract][Full Text] [Related]
11. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
12. Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial.
Shukuya T; Yamanaka T; Seto T; Daga H; Goto K; Saka H; Sugawara S; Takahashi T; Yokota S; Kaneda H; Kawaguchi T; Nagase S; Oguri T; Iwamoto Y; Nishimura T; Hattori Y; Nakagawa K; Nakanishi Y; Yamamoto N;
Lancet Oncol; 2015 Dec; 16(16):1630-8. PubMed ID: 26522337
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non-small cell lung cancer.
Pisters KM; Kris MG; Gralla RJ; Hilaris B; McCormack PM; Bains MS; Martini N
J Surg Oncol; 1994 Aug; 56(4):236-41. PubMed ID: 8057649
[TBL] [Abstract][Full Text] [Related]
14. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
Thatcher N; Hirsch FR; Luft AV; Szczesna A; Ciuleanu TE; Dediu M; Ramlau R; Galiulin RK; Bálint B; Losonczy G; Kazarnowicz A; Park K; Schumann C; Reck M; Depenbrock H; Nanda S; Kruljac-Letunic A; Kurek R; Paz-Ares L; Socinski MA;
Lancet Oncol; 2015 Jul; 16(7):763-74. PubMed ID: 26045340
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant treatment of stage IIIA non-small cell lung cancer. Long-term results.
Elias AD; Skarin AT; Gonin R; Oliynyk P; Stomper PC; O'Hara C; Socinski MA; Sheldon T; Maggs P; Frei E
Am J Clin Oncol; 1994 Feb; 17(1):26-36. PubMed ID: 8311004
[TBL] [Abstract][Full Text] [Related]
16. Long-term evaluation of intrapleural bacillus Calmette-Guerin with or without adjuvant chemotherapy in completely resected stages II and III non-small-cell lung cancer.
Macchiarini P; Hardin M; Angeletti CA
Am J Clin Oncol; 1991 Aug; 14(4):291-7. PubMed ID: 1650528
[TBL] [Abstract][Full Text] [Related]
17. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
Scagliotti GV; Fossati R; Torri V; Crinò L; Giaccone G; Silvano G; Martelli M; Clerici M; Cognetti F; Tonato M;
J Natl Cancer Inst; 2003 Oct; 95(19):1453-61. PubMed ID: 14519751
[TBL] [Abstract][Full Text] [Related]
18. Long term results of surgery and chemotherapy in small cell lung cancer.
Rea F; Callegaro D; Favaretto A; Loy M; Paccagnella A; Fantoni U; Festi G; Sartori F
Eur J Cardiothorac Surg; 1998 Oct; 14(4):398-402. PubMed ID: 9845145
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer.
Cartei G; Cartei F; Cantone A; Causarano D; Genco G; Tobaldin A; Interlandi G; Giraldi T
J Natl Cancer Inst; 1993 May; 85(10):794-800. PubMed ID: 8387607
[TBL] [Abstract][Full Text] [Related]
20. Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study).
Kreuter M; Vansteenkiste J; Fischer JR; Eberhardt WE; Zabeck H; Kollmeier J; Serke M; Frickhofen N; Reck M; Engel-Riedel W; Neumann S; Thomeer M; Schumann C; De Leyn P; Graeter T; Stamatis G; Griesinger F; Thomas M;
J Thorac Oncol; 2016 Jan; 11(1):85-93. PubMed ID: 26762743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]